13th June 2018
article written by
Cell Medica

Cell Medica Appoints Julia P. Gregory as Non-Executive Director and Audit Chair

HOUSTON and LONDON – 13 June 2018 – Cell Medica (or ‘the Company’), a leader in next generation cellular immunotherapies for the treatment of cancer, today announced the appointment of Julia P. Gregory as a Non-Executive Director and Audit Chair of the Company’s Board of Directors. Annalisa Jenkins, Chair of Cell Medica, commented: “The Board […]

Read Full Article
24th April 2018
article written by
Cell Medica

Cell and Gene Therapy Catapult manufacturing centre officially opens

  CEO Greg Sando and COO Karen Hodgkin introduce Cell Medica to Business Secretary Greg Clark and Science Minister Sam Gyimah as the Cell and Gene Therapy Catapult manufacturing centre officially opens. – Business Secretary Greg Clark and Science Minister Sam Gyimah officially opened centre – Centre will ‘bridge the gap’ between scientific research and […]

Read Full Article
20th April 2018
article written by
Cell Medica

Cell Medica team touring the new manufacturing facility in Stevenage

Cell Medica and Cell and Gene Therapy Catapult (CGT Catapult) are collaborating to establish cell therapy manufacturing for Cell Medica at the CGT Catapult’s GMP manufacturing facility in Stevenage, where we will work together on scale-up strategies for commercial production.  Today, some of the team donned their bunny suits for a tour of the facilities […]

Read Full Article
15th February 2018
article written by
Cell Medica

Cell Medica announces the appointment of Kevin Boyle as Chief Financial Officer

Cell Medica announces the appointment of Kevin Boyle as Chief Financial Officer to head up the Company’s international financial activities   Cell Medica, a leader in cellular immunotherapy for the treatment of cancer, announced today the appointment of Kevin S. Boyle, Sr. as Chief Financial Officer, based in Houston, TX. With over 20 years of financial […]

Read Full Article